Medicare GLP-1 expansion: long-term volume vs pricing
Medicare's new $50/month GLP-1 coverage opens a 20-million senior TAM for weight loss drugs, though panelists debated whether volume gains will outweigh incremental pricing pressure and commoditization.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.